Soleno Therapeutics (SLNO) Net Cash Flow: 2013-2024
Historic Net Cash Flow for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to -$81.8 million.
- Soleno Therapeutics' Net Cash Flow fell 140.13% to -$5.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$16.8 million, marking a year-over-year decrease of 382.43%. This contributed to the annual value of -$81.8 million for FY2024, which is 152.72% down from last year.
- According to the latest figures from FY2024, Soleno Therapeutics' Net Cash Flow is -$81.8 million, which was down 152.72% from $155.1 million recorded in FY2023.
- Soleno Therapeutics' Net Cash Flow's 5-year high stood at $155.1 million during FY2023, with a 5-year trough of -$81.8 million in FY2024.
- Over the past 3 years, Soleno Therapeutics' median Net Cash Flow value was -$6.7 million (recorded in 2022), while the average stood at $22.2 million.
- Per our database at Business Quant, Soleno Therapeutics' Net Cash Flow plummeted by 198.00% in 2021 and then surged by 2,413.92% in 2023.
- Soleno Therapeutics' Net Cash Flow (Yearly) stood at $28.5 million in 2020, then plummeted by 198.00% to -$27.9 million in 2021, then surged by 76.00% to -$6.7 million in 2022, then spiked by 2,413.92% to $155.1 million in 2023, then slumped by 152.72% to -$81.8 million in 2024.